Abstract
No previous study has analyzed the impact of long-term antisecretory drugs on the precision of [13C]urea breath test (UBT). We assessed the rate of UBT conversion from positive to negative results during 60-day therapy with standard doses of ranitidine and pantoprazole. For this purpose, we recruited 60 dyspeptic patients with H. pylori infection ascertained on the basis of the concomitant results of CLO-test, histology, and UBT. Our patients were randomly assigned to receive ranitidine 300 mg at night or pantoprazole 40 mg in the morning for 60 days. UBT was performed at baseline and on days 14, 30, and 60, while patients were still taking antisecretory drugs. Patients with false-negative UBT on day 60 repeated the test every 3 days until conversion. After overnight fasting, duplicate breath test samples were taken from each patient before and 30 min after ingestion of 75 mg [13C]urea dissolved in 150 ml of 0.033 mol/liter citric acid. Four patients dropped out of the study. Both drugs induced similar false-negative UBTs on day 14 of dosing (P = 0.5). Afterwards, the three false-negative UBTs in the ranitidine group again became positive during therapy and particularly on day 30 of dosing. Of the four false-negative UBTs in the pantoprazole group at day 60, one became positive after 3 and three after 9 days of therapy cessation. Our findings show that the long-term use of ranitidine and pantoprazole at standard doses has different effects on the results of UBT. In the pantoprazole group patients again became positive within 3–9 days after stopping 60-day therapy, whereas in the ranitidine group patients reverted to positive on day 30 of dosing while they were still on treatment and this was likely due to development of tolerance. Therefore, patients taking pantoprazole need at least a 10-day withdrawal before UBT testing, while those taking ranitidine for at least 30 days can undergo UBT without the necessity of a wash-out period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hopkins RJ, Giardi LS, Turney EA: Relantionship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence. A review. Gastroenterology 110:1244-1252, 1996
NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69, 1994
Nomura A, Stemmermann GN, Chyan PH, Kata I, Perez-Perez GI, Blaser MJ: Helicobacter pilori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD: Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271, 1994
Savarino V, Vigneri S, Celle G: The 13Curea breath test in the diagnosis of Helicobacter pylori infection. Gut 45(suppl I):118-122, 1999
Atherthon JC, Spiller RC: The urea breath test for Helicobacter pylori. Gut 35:723-725, 1994
Chey WD, Spybrook M, Carpenter S, Nostrant TT, Elta GH, Scheiman JM: Prolonged effect of omeprazole on the 14C urea breath test. Am. J. Gastroenterol 91:89-92, 1996
Connor SJ, Seow F, Ngu MC, Katelaris PH: The effect of dosing with omeprazole on the accuracy of the 13C urea breath test in Helicobacter pylori infected subjects. Aliment Pharmacol Ther 13:1287-1293, 1999
Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB: Effect of proton pump inhibitor therapy on diagnostic test for Helicobacter pylori. Ann Intern Med 129:547-550, 1998
Parente F, Sainaghi M, Maconi G, Sangaletti O, Imbesi V, Maconi G, Anderloni A, Bianchi Porro G: Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the 13C urea breath test. Aliment Pharmacol Ther 16:553-557, 2002
Cutler Af, Elnaggar M, Brooks E, O'Mara K: Effect of standard and high dose ranitidine on 13C urea breath test results. Am J Gastroenterol 93:1297-1299, 1998
Savarino V, Vigneri S, Zentilin P, Dulbecco P, Bilardi C, Tracci D, Mele R, Mansi C: Effect of gastric acid suppression on 13C urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther 14:291-297, 2001
Savarino V, Mela GS, Zentilin P, Bisso G, Pivari M, Mansi C, Mele MR, Bilardi C, Vigneri S, Celle G: Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C urea breath test. Am J Gastroenterol 94:1203-1208, 1999
Chey WD, Woods M, Scheiman JM, Nostrant TT, Del Valle J: Lansoprazole and ranitidine affect the accuracy of the 14Curea breath tetst by a pH-dependent mechanism. Am J Gastroenterol 92:446-450, 1992
Savarino V, Tracci D, Dulbecco P, Mele MR, Zentilin P, Mansi C, Vigneri S: Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol 96: 348-352, 2001
Racz I, Szabo A, Pesci G, Csondes M, Babarczy E: Comparison of the effects of famotidine and antiacid therapy on Curea breath test results. Gut 47(suppl 3):A131, 2000
Perri F: Diagnosis of Helicobacter pylori infection: which is the best? The urea breath test. Dig Liver Dis 32(suppl 3):S196-198, 2000
Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY: Non invasive detection of Helicobacter infection in clinical practice: The 13C urea breath. Am J Gastroenterol 91:690-696, 1996
Logan RPH, Dill S, Bauer FE, Walker MM, Hirschl AM, Gummett PA: The European 13C urea breath for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 3:915-921, 1991
Eggers RH, Kulp A, Tegeler R, Ludtke FE, Lepsien G, Meyer B, Bauer FE: A methodological analysis of the 13C urea breath for the detection of Helicobacter pylori infections: high sensitivity and specificity within 30 min using 75 mg of 13C urea breath. Eur J Gastroenterol Hepatol 2:437-444, 1990
Savarino V, Landi F, Dulbecco P, Ricci C, Tessieri L, Biagini R, Gatta L, Miglioli M, Celle G: Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): a comparative study using two doses of 13C urea and two test meals for pre-and post-treatment diagnosis of Helicobacter pylori. Dig Dis Sci 11:2168-2174, 2000
Chey WD, Chathadi KV, Montague J, Ahmed F, Murthy U: Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor. Am J Gastroenterol 96:1028-1032, 2001
Scott DR, Weeks D, Hong C, Portius S, Melchers K: The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 114:58-70, 1998
Rektorschek KM, Weeks D, Sachs G, Melchers K: Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 115:628-641, 1998
Connor SJ, Ngu MC, Katelaris PH: The impact of short-term ranitidine use on the precision of 13C urea breath test in subjects infected with Helicobacter pylori. Eur J Gastroenterol Hepatol 11:1135, 1999
Smith JTL, Gavey C, Nwokolo CU, Pounder RE: Tolerance during 8 days of high-dose H2 blockade: placebo-controlled studies of 24-hr acidity and gastrin. Aliment Pharmacol Ther 4S:47-64, 1990
Wilder-Smith CH, Ernst T: Tolerance to oral H2 receptor antagonist. Dig Dis Sci 35:976-983, 1991
Nwokolo CU, Smith JT, Sawyerr A, Gavey C, Sawyer A, Pounder RE: Tolerance during 29 days of conventional dosing with cimetidine, nizatidina, famotidine or ranitidine. Aliment Pharmacol Ther 4S:29-46, 1990
Lachmann L, Howden CW: Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Am J Gastroenterol 95(1):57-61, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dulbecco, P., Gambaro, C., Bilardi, C. et al. Impact of Long-Term Ranitidine and Pantoprazole on Accuracy of [13C]Urea Breath Test. Dig Dis Sci 48, 315–321 (2003). https://doi.org/10.1023/A:1021931627698
Issue Date:
DOI: https://doi.org/10.1023/A:1021931627698